TrialBridgeNCT07145138
UIC Multi-Ethnic DCM Registry
Recruiting · Not specified · University of Illinois Chicago · registry updated 2025-08-28
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequently and appears to causes greater harm than Whites. However, almost all research related to DCM has been performed in Whites, where up to half of cases run in the family. Several genes have been identified that cause the disease, but we are unsure if these same genes are also responsible for DCM in African Americans or Hispanic/Latino patients. The impact of various medical, social, and financial stressors on the severity of the disease in ethnic minorities also remains unclear. The investigators believe that certain genes are more common in different racial and ethnic groups and the greater medical, social, and financial burden faced by minorities in the US leads to more harm from DCM in these groups. The overall goal of the project is to test whether ethnic minority patients carrying genes that cause DCM experience more adverse effects in part because of various medical, social, and financial burdens....
Inclusion
- Must be at least 18 years of age and be admitted to or seen at a UIH site.
- Subjects must be willing and able to give written, informed consent
Exclusion
- Adults who are unable to provide consent
- Women who are pregnant at the baseline visit,
- Individuals who are not yet adults (infants, children, teenagers).